TrialProstate cancer and prostatic diseases2012

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.

R B Egerdie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.